Raphas Co Ltd
KOSDAQ:214260
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Jins Holdings Inc
TSE:3046
|
JP |
Raphas Co Ltd
Research & Development
Raphas Co Ltd
Research & Development Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Research & Development | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
R
|
Raphas Co Ltd
KOSDAQ:214260
|
Research & Development
-₩2.9B
|
CAGR 3-Years
7%
|
CAGR 5-Years
4%
|
CAGR 10-Years
N/A
|
|
|
AmorePacific Corp
KRX:090430
|
Research & Development
-₩103.7B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
-3%
|
|
|
Amorepacific Group
KRX:002790
|
Research & Development
-₩105.6B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
-3%
|
|
|
Cosmax Inc
KRX:192820
|
Research & Development
-₩2.3B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
LG H&H Co Ltd
KRX:051900
|
Research & Development
-₩21.2B
|
CAGR 3-Years
6%
|
CAGR 5-Years
9%
|
CAGR 10-Years
-2%
|
|
|
Kolmar Korea Co Ltd
KRX:161890
|
Research & Development
-₩30.9B
|
CAGR 3-Years
-12%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
-36%
|
|
Raphas Co Ltd
Glance View
RAPHAS Co., Ltd. engages in the research, development and sale of microarray patches. The company is headquartered in Seoul, Seoul. The company went IPO on 2019-11-11. The firm develops cosmetics based on microstructure technology. In addition, the Company sells cosmetics, pharmaceutical patches, health functional foods under the brand name of Acropass.
See Also
What is Raphas Co Ltd's Research & Development?
Research & Development
-2.9B
KRW
Based on the financial report for Dec 31, 2024, Raphas Co Ltd's Research & Development amounts to -2.9B KRW.
What is Raphas Co Ltd's Research & Development growth rate?
Research & Development CAGR 5Y
4%
Over the last year, the Research & Development growth was 28%. The average annual Research & Development growth rates for Raphas Co Ltd have been 7% over the past three years , 4% over the past five years .
